BPG is committed to discovery and dissemination of knowledge
Featured Articles
3/13/2025 2:05:21 PM | Browse: 90 | Download: 184
 |
Received |
|
2024-08-27 08:35 |
 |
Peer-Review Started |
|
2024-08-29 00:18 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-11-30 06:56 |
 |
Revised |
|
2024-12-13 14:08 |
 |
Second Decision |
|
2025-02-13 02:35 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-02-13 03:25 |
 |
Articles in Press |
|
2025-02-13 03:25 |
 |
Publication Fee Transferred |
|
2024-12-17 08:48 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2025-02-27 08:37 |
 |
Publish the Manuscript Online |
|
2025-03-13 10:10 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Basic Study |
Article Title |
NAD+/SIRT1 pathway regulates glycolysis to promote oxaliplatin resistance in colorectal cancer
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Ya-Ru Niu, Mi-dan Xiang, Wen-Wei Yang, Yu-Ting Fang, Hai-Li Qian and Yong-Kun Sun |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
National Natural Science Foundation of China |
82072756 |
Beijing Xisike Clinical Oncology Research Foundation |
Y-HR2019-0285 |
|
Corresponding Author |
Yong-Kun Sun, PhD, Chief Doctor, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing 100021, China. hsunyk@cicams.ac.cn |
Key Words |
Colorectal cancer; Chemotherapy resistance; Glycolysis; SIRT1; NAD+ |
Core Tip |
SIRT1, a NAD+-dependent deacetylase, has demonstrated anti-tumor effects in numerous studies. However, the role of SIRT1 in regulating oxaliplatin resistance remains unclear. This study found that SIRT1 expression is downregulated in oxaliplatin-resistant colorectal cancer (CRC) cell. Enhancing SIRT1 expression reverses this resistance. Mechanistically, DNA damage-induced PARP activation inhibits SIRT1 expression. The inhibition of SIRT1 promotes drug resistance in CRC cells by enhancing glycolysis. These findings highlight the critical role of SIRT1 in oxaliplatin resistance and support the potential of combining SIRT1 agonists with oxaliplatin as a therapeutic strategy to overcome CRC resistance. |
Publish Date |
2025-03-13 10:10 |
Citation |
<p>Niu YR, Xiang MD, Yang WW, Fang YT, Qian HL, Sun YK. NAD+/SIRT1 pathway regulates glycolysis to promote oxaliplatin resistance in colorectal cancer. <i>World J Gastroenterol</i> 2025; 31(11): 100785</p> |
URL |
https://www.wjgnet.com/1007-9327/full/v31/i11/100785.htm |
DOI |
https://dx.doi.org/10.3748/wjg.v31.i11.100785 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345